Ed Biotech announced that director and general manager Luo Jiemin plans to increase his holdings by no less than RMB 5 million and no more than RMB 10 million; Ruan Li no less than RMB 3 million and no more than RMB 6 million; Chen Ying not less than RMB 4 million and no more than RMB 8 million; and Zheng Huibin and Wang Hongyu respectively. The above plan to increase holdings is intended to be implemented through centralized bidding transactions within three months from the date of disclosure of the announcement, without setting a price range.

Ed Biotech announced that director and general manager Luo Jiemin plans to increase his holdings by no less than RMB 5 million and no more than RMB 10 million; Ruan Li no less than RMB 3 million and no more than RMB 6 million; Chen Ying not less than RMB 4 million and no more than RMB 8 million; and Zheng Huibin and Wang Hongyu respectively. The above plan to increase holdings is intended to be implemented through centralized bidding transactions within three months from the date of disclosure of the announcement, without setting a price range.